Published in Diabetes on June 30, 2008
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice. Nat Neurosci (2014) 2.58
MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev (2010) 2.51
MicroRNA and cancer--focus on apoptosis. J Cell Mol Med (2009) 2.44
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome (2009) 1.87
MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol (2009) 1.77
microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells. Blood (2009) 1.75
miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J (2011) 1.75
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes (2011) 1.56
miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol (2010) 1.43
Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39
Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice. Diabetes (2012) 1.32
Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res (2011) 1.30
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis (2009) 1.29
The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One (2009) 1.25
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat Med (2013) 1.25
The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One (2013) 1.25
Novel microRNAs differentially expressed during aging in the mouse brain. PLoS One (2012) 1.20
MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem (2012) 1.19
Roles of microRNA on cancer cell metabolism. J Transl Med (2012) 1.11
Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci (2011) 1.11
miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/β-catenin pathway. Nucleic Acids Res (2013) 1.11
MicroRNAs in insulin resistance and obesity. Exp Diabetes Res (2012) 1.10
Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab (2013) 1.08
Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One (2011) 1.04
Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics (2012) 1.01
miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. Am J Transl Res (2014) 1.01
Chronic reduction of the cytosolic or mitochondrial NAD(P)-malic enzyme does not affect insulin secretion in a rat insulinoma cell line. J Biol Chem (2009) 1.00
Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia (2011) 0.99
Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol (2015) 0.98
MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice. Gastroenterology (2013) 0.97
microRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol (2010) 0.97
MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8. J Biol Chem (2013) 0.95
Regulation of microRNA-375 by cAMP in pancreatic β-cells. Mol Endocrinol (2012) 0.92
miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol (2010) 0.92
Regulation of Adipocyte Differentiation via MicroRNAs. Endocrinol Metab (Seoul) (2014) 0.92
Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J Cell Sci (2013) 0.92
MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells. BMC Cancer (2014) 0.91
MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin Exp Pharmacol Physiol (2011) 0.90
microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal (2014) 0.90
Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int J Mol Sci (2014) 0.89
Regulation of Aerobic Glycolysis by microRNAs in Cancer. Mol Cell Pharmacol (2011) 0.89
Post-transcriptional regulation in metabolic diseases. RNA Biol (2012) 0.88
MicroRNAs as pharmacological targets in diabetes. Pharmacol Res (2013) 0.88
Dysregulation of Dicer1 in beta cells impairs islet architecture and glucose metabolism. Exp Diabetes Res (2012) 0.88
Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes (2013) 0.88
MicroRNAs: a new ray of hope for diabetes mellitus. Protein Cell (2012) 0.87
Biochemical adaptations of mammalian hibernation: exploring squirrels as a perspective model for naturally induced reversible insulin resistance. Braz J Med Biol Res (2013) 0.87
Role of MicroRNA in pancreatic beta-cells: where more is less. Diabetes (2008) 0.87
MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PLoS One (2015) 0.87
MicroRNAs as newer therapeutic targets: A big hope from a tiny player. J Pharmacol Pharmacother (2012) 0.87
Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians. Diabetes (2014) 0.86
Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Med Hypotheses (2013) 0.86
Circulating MicroRNAs as Biomarkers in Health and Disease. J Clin Diagn Res (2012) 0.85
Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. Genes (Basel) (2014) 0.85
MiR-375 promotes redifferentiation of adult human β cells expanded in vitro. PLoS One (2015) 0.84
β-Cell MicroRNAs: Small but Powerful. Diabetes (2015) 0.84
Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep (2015) 0.83
MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma. Am J Cancer Res (2015) 0.82
miRConnect: identifying effector genes of miRNAs and miRNA families in cancer cells. PLoS One (2011) 0.82
Insulin producing cells derived from embryonic stem cells: are we there yet? J Cell Physiol (2009) 0.82
MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma. Oncol Lett (2013) 0.82
Expression levels of microRNA-375 in pancreatic cancer. Biomed Rep (2013) 0.82
miR-375 and miR-30d in the effect of chromium-containing Chinese medicine moderating glucose metabolism. J Diabetes Res (2014) 0.81
A simple matter of life and death-the trials of postnatal Beta-cell mass regulation. Int J Endocrinol (2012) 0.81
MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. J Biol Chem (2015) 0.81
Emerging role of the KRAS-PDK1 axis in pancreatic cancer. World J Gastroenterol (2014) 0.80
Minireview: microRNA function in pancreatic β cells. Mol Endocrinol (2014) 0.80
Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells. Mol Endocrinol (2015) 0.80
Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep (2016) 0.80
Role of microRNAs in islet beta-cell compensation and failure during diabetes. J Diabetes Res (2014) 0.80
RNA Regulation of Lipotoxicity and Metabolic Stress. Diabetes (2016) 0.79
MicroRNA-375 overexpression influences P19 cell proliferation, apoptosis and differentiation through the Notch signaling pathway. Int J Mol Med (2015) 0.77
miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction. Lab Invest (2015) 0.77
Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells. Epigenetics (2016) 0.76
DNA methylation of microRNA-375 in impaired glucose tolerance. Exp Ther Med (2014) 0.76
miR-29a promotes myocardial cell apoptosis induced by high glucose through down-regulating IGF-1. Int J Clin Exp Med (2015) 0.76
Brief review: cell replacement therapies to treat type 1 diabetes mellitus. Clin Diabetes Endocrinol (2016) 0.75
Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1. PLoS One (2017) 0.75
β-cell preservation and regeneration for diabetes treatment: where are we now? Diabetes Manag (Lond) (2012) 0.75
Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats. Int J Mol Sci (2016) 0.75
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus. J Hum Genet (2016) 0.75
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links? Curr Diab Rep (2017) 0.75
A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis. Sci Rep (2016) 0.75
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. Stem Cell Reports (2017) 0.75
MiRNAs in β-Cell Development, Identity, and Disease. Front Genet (2017) 0.75
MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochim Biophys Acta (2016) 0.75
MicroRNA let-7b-regulated epidermal stem cell proliferation in hypertrophied anal papillae. Mol Med Rep (2015) 0.75
MicroRNAs as stress regulators in pancreatic beta cells and diabetes. Mol Metab (2017) 0.75
Connexins and microRNAs: interlinked players in regulating islet function? Islets (2017) 0.75
Role of microRNAs in obesity and obesity-related diseases. Genes Nutr (2017) 0.75
Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion. Rev Diabet Stud (2016) 0.75
Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes. Rev Diabet Stud (2016) 0.75
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases. Front Med (Lausanne) (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 39.31
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol (2005) 18.94
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol (1997) 15.32
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41
The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol (2003) 11.23
Type 2 diabetes: principles of pathogenesis and therapy. Lancet (2005) 10.71
Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol (2006) 10.67
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 9.97
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res (2005) 9.80
The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell (2007) 7.99
Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science (1998) 6.79
MicroRNA-143 regulates adipocyte differentiation. J Biol Chem (2004) 6.78
Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer (2007) 6.57
Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res (2005) 5.44
A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res (2004) 5.21
Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes (2004) 4.73
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene (2007) 4.46
microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet (2007) 3.63
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol (2007) 3.04
Essential role of PDK1 in regulating cell size and development in mice. EMBO J (2002) 2.93
Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes (2007) 2.81
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol (2007) 2.61
MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem (2006) 2.29
MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem (2007) 2.15
Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet (2006) 2.05
PDK1 regulates growth through Akt and S6K in Drosophila. Proc Natl Acad Sci U S A (2001) 1.85
MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol (2007) 1.81
Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest (1996) 1.55
Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab (2002) 1.36
Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia (1994) 1.36
Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells. J Biol Chem (2006) 1.31
Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner. Biochem J (1994) 1.25
Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J Biol Chem (2005) 1.24
Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem (2007) 1.21
Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem (2000) 1.21
Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi. Biochem J (2005) 1.01
Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes (1996) 0.98
Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity. Diabetes (2006) 0.95
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med (2005) 10.16
Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res (2010) 4.25
Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol (2005) 2.06
IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas. EMBO J (2006) 2.02
Screening for insulitis in adult autoantibody-positive organ donors. Diabetes (2007) 2.02
Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol (2002) 1.79
Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci U S A (2006) 1.60
Beta-cell replication is increased in donor organs from young patients after prolonged life support. Diabetes (2010) 1.55
Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A (2008) 1.52
Malnutrition is an independent factor associated with nosocomial infections. Br J Nutr (2004) 1.51
Use of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis. Am J Clin Pathol (2010) 1.42
Use of the Cell-Dyn Sapphire hematology analyzer for automated counting of blood cells in body fluids. Am J Clin Pathol (2010) 1.38
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood (2009) 1.37
Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes (2002) 1.27
Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J Biol Chem (2005) 1.24
Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Free Radic Biol Med (2006) 1.24
Correlation between GABA release from rat islet beta-cells and their metabolic state. Am J Physiol Endocrinol Metab (2002) 1.21
Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes (2006) 1.19
Critical role for cataplerosis via citrate in glucose-regulated insulin release. Diabetes (2002) 1.17
PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation. J Biol Chem (2004) 1.17
Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS One (2012) 0.97
Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity. Diabetes (2006) 0.95
Glucagon-like peptide-1 stimulates GABA formation by pancreatic beta-cells at the level of glutamate decarboxylase. Am J Physiol Endocrinol Metab (2006) 0.95
Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes (2008) 0.94
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. J Autoimmun (2013) 0.94
Beta cell count instead of beta cell mass to assess and localize growth in beta cell population following pancreatic duct ligation in mice. PLoS One (2012) 0.94
Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts. J Vasc Interv Radiol (2005) 0.93
Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. PLoS One (2009) 0.93
Myelination and motor coordination are increased in transferrin transgenic mice. J Neurosci Res (2003) 0.92
Peroxisome proliferator-activated receptor alpha-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity. FEBS J (2007) 0.91
Glucose, regulator of survival and phenotype of pancreatic beta cells. Vitam Horm (2009) 0.91
Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Biochem Pharmacol (2008) 0.90
Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice. J Nutr (2002) 0.90
Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes (2004) 0.89
miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes. Biochem Biophys Res Commun (2009) 0.89
Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Biochem Pharmacol (2004) 0.88
Comparative evaluation of simple indices of graft function after islet transplantation. Transplantation (2011) 0.88
Conditional hypovascularization and hypoxia in islets do not overtly influence adult β-cell mass or function. Diabetes (2013) 0.87
Growth and functional maturation of beta-cells in implants of endocrine cells purified from prenatal porcine pancreas. Diabetes (2005) 0.86
Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells. J Endocrinol (2010) 0.86
Plasma protein binding of luciferase substrates influences sensitivity and accuracy of bioluminescence imaging. Mol Imaging Biol (2011) 0.86
Ectopic expression of E2F1 stimulates beta-cell proliferation and function. Diabetes (2010) 0.85
Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivo. Diabetes (2013) 0.85
Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. Diabetes (2002) 0.85
Population structures of Brazilian tall coconut (Cocos nucifera L.) by microsatellite markers. Genet Mol Biol (2010) 0.84
Convulsions and apnoea in a patient infected with New Delhi metallo-β-lactamase-1 Escherichia coli treated with colistin. J Infect (2011) 0.84
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation (2009) 0.83
Investigation and characterization of the duct cell-enriching process during serum-free suspension and monolayer culture using the human exocrine pancreas fraction. Pancreas (2009) 0.82
Evaluation of the INS-1 832/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function. PLoS One (2013) 0.81
Comparison of cellular and medium insulin and GABA content as markers for living beta-cells. Am J Physiol Endocrinol Metab (2004) 0.81
Variations in IB1/JIP1 expression regulate susceptibility of beta-cells to cytokine-induced apoptosis irrespective of C-Jun NH2-terminal kinase signaling. Diabetes (2003) 0.80
Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies. MAbs (2013) 0.80
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. Transplantation (2008) 0.80
Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance. Diabetes Care (2004) 0.80
Automated validation of clinical laboratory test results: do we get what we expect? Clin Chem Lab Med (2009) 0.79
Xenotransplantation of purified pre-natal porcine beta cells in mice normalizes diabetes when a short anti-CD4-CD8 antibody treatment is combined with transient insulin injections. Xenotransplantation (2006) 0.78
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies. Diabetes Care (2009) 0.78
Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. Transplantation (2013) 0.78
Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect. Genet Med (2012) 0.78
Glucose inhibits GABA release by pancreatic beta-cells through an increase in GABA shunt activity. Am J Physiol Endocrinol Metab (2005) 0.77
Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients. Diabetes Care (2013) 0.76
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. Transplantation (2014) 0.75
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients. Diabetes Metab Res Rev (2011) 0.75
Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells. Cell Transplant (2014) 0.75
Enzymatic pyruvate measurement by Cobas 6000 open channel assay. Clin Lab (2012) 0.75
Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under Anti-thymocyte globulin - Mycophenolate mofetil - Tacrolimus immune suppression. Transplantation (2016) 0.75
Functional interactions between pancreatic beta cells and (pre)adipocytes. Endocrine (2010) 0.75
Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism. Cell Transplant (2011) 0.75
Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet. FEBS Lett (2004) 0.75